Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $608,685 - $729,960
38,500 Added 32.63%
156,500 $2.82 Billion
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $1.55 Million - $2.11 Million
-121,000 Reduced 50.63%
118,000 $1.92 Billion
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $1.82 Million - $2.46 Million
-170,400 Reduced 41.62%
239,000 $3.37 Billion
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $3.32 Million - $4.35 Million
409,400 New
409,400 $4.27 Billion

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Crawford Fund Management, LLC Portfolio

Follow Crawford Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Fund Management, LLC with notifications on news.